oxybutynin has been researched along with Liver Diseases in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Blood and urine samples were collected to evaluate pharmacokinetic parameters characterizing drug bioavailability and elimination." | 2.79 | Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotine. ( Boekens, H; Braun, M; Cawello, W; Fichtner, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cawello, W | 1 |
| Fichtner, A | 1 |
| Boekens, H | 1 |
| Braun, M | 1 |
1 trial available for oxybutynin and Liver Diseases
| Article | Year |
|---|---|
Influence of hepatic impairment on the pharmacokinetics of the dopamine agonist rotigotine.
Topics: Administration, Cutaneous; Adult; Area Under Curve; Biological Availability; Biotransformation; Dopa | 2014 |